Pharma News, 2022

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health con...

Biotech Nektar Therapeutics and its partner Bristol Myers Squibb said early Monday that their cancer drug known as bempeg had failed in a trial in melanoma patients. ...

For the first time, an international group of experts has issued recommendations to doctors about how to distinguish between true side effects caused by statins that have been prescribed in order ...

The discovery, published in the scientific journal Cell, results from a collaboration of scientists at the Max Planck Florida Institute for Neuroscience, HHMI's Janelia Research Campus, the Allen ...

You regularly can't remember where you left your phone or your book. You keep missing appointments. You often lose your train of thought during conversation.

The US Food and Drug Administration (FDA) has declined to grant approval to AstraZeneca’s Fasenra (benralizumab) to treat individuals with inadequately controlled chronic rhinosinusitis with nasa...

The FDA granted fast track designation to ALLO-316, an investigational chimeric antigen receptor T-cell therapy, for the treatment of adults with advanced or metastatic clear cell renal cell carcinoma...

Pfizer will gain access to Arena’s portfolio of various treatment candidates for gastroenterology, dermatology and cardiology.

On March 11, 2022, the Food and Drug Administration approved olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) for the adjuvant treatment of adult patients with deleterious or suspected deleter...

Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in ...

Physicists, chemists and immunologists at McMaster University have teamed up to modify red blood cells to transport viral agents which can safely trigger the immune system to protect the body again...